 |
BioWorld-International-2011-08-10
Russia's SynBio Purchases Majority Stake in UK's Lipoxen
Russia's SynBio Purchases Majority Stake in UK's Lipoxen
LONDON – Drug delivery specialist Lipoxen plc is selling a majority, £12.8 million (US$20.9 million), stake in the company to SynBio LLC, a firm that is majority-owned by the government of Russia, as one of a series of moves to transform itself into a mainstream drug developer. (BioWorld International)